113 related articles for article (PubMed ID: 23254898)
21. Goodpasture autoantibodies unmask cryptic epitopes by selectively dissociating autoantigen complexes lacking structural reinforcement: novel mechanisms for immune privilege and autoimmune pathogenesis.
Borza DB; Bondar O; Colon S; Todd P; Sado Y; Neilson EG; Hudson BG
J Biol Chem; 2005 Jul; 280(29):27147-54. PubMed ID: 15917228
[TBL] [Abstract][Full Text] [Related]
22. Presentation of the Goodpasture autoantigen to CD4 T cells is influenced more by processing constraints than by HLA class II peptide binding preferences.
Phelps RG; Jones VL; Coughlan M; Turner AN; Rees AJ
J Biol Chem; 1998 May; 273(19):11440-7. PubMed ID: 9565555
[TBL] [Abstract][Full Text] [Related]
23. Goodpasture syndrome. Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the alpha 3(IV) chain of basement membrane collagen.
Kalluri R; Gunwar S; Reeders ST; Morrison KC; Mariyama M; Ebner KE; Noelken ME; Hudson BG
J Biol Chem; 1991 Dec; 266(35):24018-24. PubMed ID: 1721062
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
25. Point mutations of single amino acids abolish ability of alpha3 NC1 domain to elicit experimental autoimmune glomerulonephritis in rats.
Hellmark T; Chen L; Ohlsson S; Wieslander J; Bolton WK
J Biol Chem; 2003 Nov; 278(47):46516-22. PubMed ID: 12970356
[TBL] [Abstract][Full Text] [Related]
26. Alport alloantibodies but not Goodpasture autoantibodies induce murine glomerulonephritis: protection by quinary crosslinks locking cryptic α3(IV) collagen autoepitopes in vivo.
Luo W; Wang XP; Kashtan CE; Borza DB
J Immunol; 2010 Sep; 185(6):3520-8. PubMed ID: 20709951
[TBL] [Abstract][Full Text] [Related]
27. Modeling of human anti-GBM antibody-alpha3(IV)NC1 interactions predicts antigenic cross-linking through contact of both heavy chains with repeating epitopes on alpha3(IV)NC1.
Meyers KE; Christensen M; Madaio MP
Am J Nephrol; 2009; 30(5):474-80. PubMed ID: 19786737
[TBL] [Abstract][Full Text] [Related]
28. A nephritogenic peptide induces intermolecular epitope spreading on collagen IV in experimental autoimmune glomerulonephritis.
Chen L; Hellmark T; Pedchenko V; Hudson BG; Pusey CD; Fox JW; Bolton WK
J Am Soc Nephrol; 2006 Nov; 17(11):3076-81. PubMed ID: 17005930
[TBL] [Abstract][Full Text] [Related]
29. Recovery of a human natural antibody against the noncollagenous-1 domain of type IV collagen using humanized models.
Worni-Schudel IM; Clark AG; Chien T; Hwang KK; Chen BJ; Foster MH
J Transl Med; 2015 Jun; 13():185. PubMed ID: 26048777
[TBL] [Abstract][Full Text] [Related]
30. Central tolerance regulates B cells reactive with Goodpasture antigen alpha3(IV)NC1 collagen.
Zhang Y; Su SC; Hecox DB; Brady GF; Mackin KM; Clark AG; Foster MH
J Immunol; 2008 Nov; 181(9):6092-100. PubMed ID: 18941198
[TBL] [Abstract][Full Text] [Related]
31. T cell responses to peptides of Goodpasture autoantigen in patients with anti-glomerular basement membrane disease.
Hu SY; Jia XY; Gu QH; Yu CY; Cheng XY; Jin QZ; Zhou FD; Cui Z; Zhao MH
Nephrology (Carlton); 2018 Apr; 23(4):345-350. PubMed ID: 28152559
[TBL] [Abstract][Full Text] [Related]
32. Epitope analysis of the Goodpasture antigen using a resonant mirror biosensor.
Levy JB; Turner AN; George AJ; Pusey CD
Clin Exp Immunol; 1996 Oct; 106(1):79-85. PubMed ID: 8870702
[TBL] [Abstract][Full Text] [Related]
33. Molecular properties of the Goodpasture epitope.
Gunnarsson A; Hellmark T; Wieslander J
J Biol Chem; 2000 Oct; 275(40):30844-8. PubMed ID: 10896942
[TBL] [Abstract][Full Text] [Related]
34. High throughput functional epitope mapping: revisiting phage display platform to scan target antigen surface.
Rojas G; Tundidor Y; Infante YC
MAbs; 2014; 6(6):1368-76. PubMed ID: 25484050
[TBL] [Abstract][Full Text] [Related]
35. Specificity of circulating and tissue-bound autoantibodies in Goodpasture syndrome.
Kalluri R; Melendez E; Rumpf KW; Sattler K; Müller GA; Strutz F; Neilson EG
Proc Assoc Am Physicians; 1996 Mar; 108(2):134-9. PubMed ID: 8705733
[TBL] [Abstract][Full Text] [Related]
36. Glomerulopathy induced by immunization with a peptide derived from the goodpasture antigen α3IV-NC1.
Hopfer H; Hünemörder S; Treder J; Turner JE; Paust HJ; Meyer-Schwesinger C; Hopfer U; Sachs M; Peters A; Bucher-Kocaoglu B; Ahrens S; Panzer U; Mittrücker HW
J Immunol; 2015 Apr; 194(8):3646-55. PubMed ID: 25769923
[TBL] [Abstract][Full Text] [Related]
37. A role for collagen IV cross-links in conferring immune privilege to the Goodpasture autoantigen: structural basis for the crypticity of B cell epitopes.
Vanacore RM; Ham AJ; Cartailler JP; Sundaramoorthy M; Todd P; Pedchenko V; Sado Y; Borza DB; Hudson BG
J Biol Chem; 2008 Aug; 283(33):22737-48. PubMed ID: 18499662
[TBL] [Abstract][Full Text] [Related]
38. Uncommon structural motifs dominate the antigen binding site in human autoantibodies reactive with basement membrane collagen.
Foster MH; Buckley ES; Chen BJ; Hwang KK; Clark AG
Mol Immunol; 2016 Aug; 76():123-33. PubMed ID: 27450516
[TBL] [Abstract][Full Text] [Related]
39. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.
Ooi JD; Holdsworth SR; Kitching AR
J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of the noncollagenous NC1 domain of type IV collagen: identification of structural features important for assembly, function, and pathogenesis.
Netzer KO; Suzuki K; Itoh Y; Hudson BG; Khalifah RG
Protein Sci; 1998 Jun; 7(6):1340-51. PubMed ID: 9655338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
